A Phase I, Single-centre, Single-blind, Randomised, Placebo-controlled, Single-dose Study to Assess the Safety, Tolerability and Pharmacokinetics After Single Ascending Intravenous Doses of AZD2927 in Healthy Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 May 2011
At a glance
- Drugs AZD 2927 (Primary)
- Indications Arrhythmias
- Focus Adverse reactions
- 23 May 2011 Actual end date (May 2011) added as reported by ClinicalTrials.gov.
- 23 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 15 Feb 2011 Actual initiation date (Jan 2011) added as reported by ClinicalTrials.gov.